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Neurotrophic factors are relevant regulators of the neurogenic process at different
levels. In particular, the brain-derived neurotrophic factor, BDNF, is highly expressed
in the hippocampus (HC) of rodents and participates in the control of neuronal
proliferation, and survival in the dentate gyrus (DG). Likewise, serotonin is also involved
in the regulation of neurogenesis, though its role is apparently more complex. Indeed,
both enhancement of serotonin neurotransmission as well as serotonin depletion,
paradoxically increase neuronal survival in the HC of mice. In this study, we analyzed
the protein expression of the BDNF isoforms, i.e., pro- and mature-BDNF, and their
respective receptors p75 and TrkB, in the HC of mice chronically treated with para-
chloro-phenyl-alanine (PCPA), an inhibitor of serotonin synthesis. The same analysis
was conducted in hyposerotonergic mice with concomitant administration of the 5-
HT1A receptor agonist, 8-Hydroxy-2-(di-n- propylamino) tetralin (8-OH-DPAT). Increased
expression of p75 receptor with decreased expression of pro-BDNF was observed
after chronic PCPA. Seven-day treatment with 8-OH-DPAT reestablished the expression
of pro-BDNF modified by PCPA, and induced an increase in the expression of p75
receptor. It has been demonstrated that PCPA-treated mice have higher number of
immature neurons in the HC. Given that immature neurons participate in the pattern
separation process, the object pattern separation test was conducted. A better
performance of hyposerotonergic mice was not confirmed in this assay. Altogether, our
results show that molecules in the BDNF signaling pathway are differentially expressed
under diverse configurations of the serotonergic system, allowing for fine-tuning of the
neurogenic process.
Keywords: BDNF signaling pathway, serotonin depletion, 5-HT1A receptor, mice model, newborn neurons survival,
pattern separation
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INTRODUCTION
With the extension of life expectancy, several pathologies
affecting the central nervous system have gained greater
visibility. In this context, disentangling the etiopathogenesis
of neurodegenerative diseases and seeking for more effective
therapies represent key challenges. Strategies to replace lost
neurons because of neurodegenerative processes are focused on
two types of interventions: on the one hand, transplantation
of exogenous nerve cells and, on the other, the use of the
endogenous neural niches still active in the adult nervous
system (Boda et al., 2017). Indeed, neurogenic potential has
been specifically characterized in the hippocampus (HC) and
the subventricular zone of adult mammal brains (Gage, 2000).
However, a thorough knowledge of the molecular mechanisms
controlling neurogenesis and its possible manipulation in
pathological conditions is required in view of its therapeutic
use. In this sense, neurotrophic factors have recently emerged
as regulators of the neurogenic process at different levels (see
review in Vilar and Mira, 2016). In particular, the brain-
derived neurotrophic factor, BDNF, is highly expressed in
the HC of rodents (Aid et al., 2007), and its role in the
regulation of the proliferation and survival of newborn neurons
in the dentate gyrus (DG) has been extensively studied (see
review in Foltran and Diaz, 2016). BDNF is secreted as pro-
BDNF, a proneurotrophin which can be converted to mature
BDNF (mBDNF). Pro-BDNF acting through the p75 receptor
is responsible for pro-apoptotic actions, whereas mBDNF-TrkB
receptors complex mediates pro-neurogenic effects. Globally, the
actions of both BDNF isoforms contribute to the regulation of
neuronal homeostasis.
At the beginning of this century, an original report showed
that chronic administration of serotonin selective reuptake
inhibitors antidepressants is able to induce neurogenesis in
the HC of adult rats (Malberg et al., 2000). Since this pivotal
discovery, the neurogenic actions of serotonergic drugs were
extensively proved in the adult HC of mice and even in humans
(see review in Kempermann et al., 2018). However, the specific
role of serotonin is still unclear, since increased neuronal survival
is also described in the HC of diverse mice models of constitutive
(Diaz et al., 2013; Karabeg et al., 2013; Sachs et al., 2013; Song
et al., 2017) as well as induced (Jia et al., 2014; Song et al., 2016)
serotonin depletion. Particularly, we have previously reported
increased survival of 1 week- and 4 week- old newborn neurons
in the DG of mice chronically treated with PCPA during 5 and
8 weeks, respectively (Diaz et al., 2013). These paradoxical effects,
i.e., supernumerary newborn neurons in the DG of mice with
either increased or decreased serotonergic neurotransmission,
could be partially explained by the participation of one or several
of the serotonin receptors subtypes. Indeed, stimulation of 5-
HT1A receptor for 7 days was enough to reestablish the increased
survival of 1-week-old neurons shown in hyposerotonergic
mice, induced either by genetic, or pharmacological ablation
(Diaz et al., 2013).
Immature neurons in the DG appear to be responsible for
enhanced pattern separation, i.e., the ability to discriminate
between two very similar but different spatial contexts (Sahay
et al., 2011; Nakashiba et al., 2012). Nevertheless, we have
shown that hyposerotonergic Pet1−/− mice, displaying increased
number of immature neurons in the DG, and have a normal
performance in contextual fear-discrimination learning (Diaz
et al., 2013). A recently developed test, called object pattern
separation (van Hagen et al., 2015), provides the opportunity to
measure both deterioration, and improvement in the ability of
pattern separation. It is based on the natural tendency of rodents
to explore an object that is new to them, so they do not have
to be trained for a special skill and it is not highly stressful to
the animals. Likewise, its highest resolution allows finding subtle
differences, which may shed light in the search for the specific role
of immature neurons in hyposerotonergic mice models.
We analyze here the protein expression of the BDNF signaling
pathway in the HC of hyposerotonergic mice, revealing changes
in the expression of p75 receptor and pro-BDNF. Likewise,
7-day treatment with a 5-HT1A receptor agonist to these
mice partially reversed changes induced by serotonin depletion.
Finally, hyposerotonergic mice did not performed better than
control mice in the objet pattern separation test.
MATERIALS AND METHODS
Animals
Studies were performed on 102 male, C57BL/6 elite mice
purchased at the Instituto de Medicina Experimental, Academia
Nacional de Medicina, Buenos Aires, Argentina. Experiments
on animals were conducted according to local regulations and
were approved by the Institutional Ethical Committee (UBA-
FMED, Resol. 2016/1637 and 2019/297). Three-four week-old
mice, bred in barrier-conditions to maintain an SPF status,
were transported in environmentally controlled conditions to our
institute’s animal facility. After arrival, mice were housed in 1284L
Eurostandard Type II Long (365 mm × 207 mm × 140 mm)
Tecniplast microisolator cages with filter tops (five to seven
animals per cage), with autoclavated aspen shavings as bedding
and tissue paper as nesting material. Mice were maintained under
controlled conditions, i.e., 22 ± 2◦C room temperature, 60%
relative humidity, 12–12 h light–dark cycle (lights on at 8 a.m.),
pelleted food for rodents (Cooperación) and water ad libitum.
Cages were changed twice a week. A period of acclimation
of 2 weeks was left before the beginning of experiments, and
therefore, mice were 5–6 week-old when treatments begun.
Serotonin Depletion Protocol
Serotonin depletion in mice was induced by oral administration
of para-chloro-phenyl-alanine (PCPA), an inhibitor of the rate
limiting enzime tryptophane hydroxylase, during 8 weeks, as
previously described (Foltran et al., 2019). Briefly, PCPA was
suspended in a 0,5% carboxymethyl cellulose solution and mixed
in gelatin palatable cubes. Mice were divided into two groups.
One group received cubes with PCPA at an estimated dose of
500 mg/kg on days 1 and 2, and 250 mg/kg PCPA for the rest
of the treatment (69 mg/cube, and 34.5 mg/cube respectively, per
cage with 6 mice). The control group received similar cubes with
vehicle. A PCPA or vehicle containing cube was given per cage,
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every day between 2 p.m. and 5 p.m. Serotonin depletion in the
HC (75%) and cortex (60%) of mice was confirmed by HPLC
as soon as 10 days after the beginning of PCPA administration
(Foltran et al., 2019).
Experiment 1: Expression of the BDNF
Signaling Pathway
Chronic PCPA treatment during 8 weeks increases survival of
4 week-old neurons in the HC (Diaz et al., 2013). To study the
potential involvement of the BDNF signaling pathway in these
neurogenic effects, the protein expression of BDNF isoforms and
their receptors was studied by western blotting. After 8 week of
PCPA (n = 6) or vehicle (n = 5) administration, mice were killed
by cervical dislocation and both HC were obtained. Tissue was
homogenized with 250 µl of RIPA buffer along with protease
inhibitors (150 mM NaCl, 1% NP-40, 0.5% Sodium deoxycholate,
0.1% SDS, 50 mM Tris) and centrifuged at 4◦C for 30 min at
13000 (r/min). The supernatants were recovered and proteins
levels were quantified by the Bradford protein assay. Samples
(50 µgr in 5× loading buffer) were then loaded into SDS-PAGE
gels (12 or 15%) and transferred onto nitrocellulose membranes
using the Mini-PROTEAN R©Tetra System (BIO-RAD) for 1 h.
Western Blotting
Membranes were incubated for 1 h with blocking solution
(5% milk in TBST) and then probed overnight at 4◦C with
mouse anti-BDNF (1:2000; Icosagen; 327-100 clone 3C11), rabbit
anti-p75 (1:700; Alomone Labs; ANT-007), rabbit anti-TrkB
(1:700; Alomone Labs; ANT-019), and rabbit anti-proBDNF
(1:250; Abcam; ab72440) in TBST. β-III Tubulin was used as
a loading control (1:2500; R&D Systems). Binding of primary
antibodies was visualized with anti-mouse HRP-conjugated
secondary antibody (1:3000; BIO-RAD) or anti-rabbit HRP-
conjugated secondary antibody (1:3000; BIO-RAD). Membranes
were developed using the ECL Plus Western blotting substrate
(Thermo Fisher Scientific) for chemifluorescence with the
Storm R©Molecular Imager. Densitometry was carried out using
ImageJ software (Schneider et al., 2012). The signal of each
protein is expressed after subtraction of background signal and
related to tubulin signal.
Experiment 2: Chronic Treatment With
the 5-HT1A Agonist, 8-OH-DPAT
We have previously reported that chronic PCPA induced
increased survival of 1 week- and 4 week-old newborn neurons
corresponding to 5 and 8 weeks of PCPA administration,
respectively (Diaz et al., 2013). Also we have shown that
stimulation of the 5-HT1A receptor for 7 days is able to
reestablish the basal level of survival of 1 week-old newborn
neurons in the HC of PCPA-chronically treated mice (Diaz
et al., 2013). To study the role of this serotonin receptor on
the BDNF signaling pathway of hyposerotonergic mice, the 5-
HT1A receptor agonist 8-Hydroxy-2-(di-n- propylamino)tetralin
(8-OH-DPAT) was administered to a group of PCPA- (n = 11)
or vehicle- (n = 12) treated mice. Mice received palatable cubes
with PCPA or vehicle for 4 weeks, as explained above. On
the 5th week, animals continued receiving PCPA or vehicle,
and simultaneously received two daily intraperitoneal (i.p.)
injections of 8-OH-DPAT at 0.5 mg/kg or vehicle (NaCl 0.9%)
for 7 days as previously described (Diaz et al., 2013). Mice were
killed by cervical dislocation on the day of the last injection
and HC were collected. Western blotting was performed as
already described.
Experiment 3: Object Pattern Separation
(OPS) Test in Hyposerotonergic Mice
For an initial set up of the object pattern separation (OPS)
test in our experimental conditions, the protocol described by
van Hagen et al. (2015), was followed with few modifications.
A 27 cm diameter-round open field with red walls was employed
(Figure 3A). This arena was placed inside a bigger black square
open field with visual cues fixed in each wall. Briefly, mice were
divided into 5 groups (n = 8/experimental group) and habituated
for 3 days to the open field without any objects. They were placed
in the arena and left for 10 min to explore. Mice were then
tested 48 hs after the last habituation session. First, in a pre-
test session, they were presented two identical objects placed in
two symmetrical spots in the center of the arena. The objects
were caramel color bottles of 7 cm of height filled with a dark
solution so that mice were not able to move them. Animals
were left 4 min to explore. The test session was performed 1 h
later, where one of the objects was placed in a novel location
inside the arena 2, 4, 6, or 8 cm away from the initial location
(positions 2, 3, 4, and 5, respectively). Position 1 meant no change
in any object. Each group was assigned a different position. Mice
were left again 4 min to explore. Time spent exploring each
object in both sessions was recorded. Exploration was defined as
directing the nose toward the object at a distance of no more
than 2 cm and/or touching the object with the nose. Sitting
on the object was not considered as exploratory behavior. Mice
that spent less than 10 s in total exploratory time in the pre-
test or test were eliminated from the data, since it has been
shown that animals require at least 10 s of object interaction for
reliable object discrimination (şik et al., 2003; Akkerman et al.,
2012). Exploration time was measured manually in a computer
with the Solomon Coder program. A discriminatory index was
calculated, as “(time spent exploring the moved object – time
spent exploring the stationary object)/total exploratory time.”
According to the results of the set up, the position 3 was chosen
to test treated mice.
To study the effects of PCPA treatment on the process of
pattern separation, mice were divided in two groups (n = 13–
15), and received a palatable cube containing either PCPA
or vehicle during 8 weeks, as described above. PCPA was
administered as a tool to increase the survival of newborn
neurons in the HC (Diaz et al., 2013). The OPS test was
conducted as described above, on the 7th week of PCPA
or vehicle treatment. All habituation and test sessions were
recorded, and videos were analyzed to measure exploratory
activity. Distance moved by mice in the habituation videos
were used to quantify locomotor activity, via EthoVision XT 14.
Time spent exploring each object in both, the pre-test or test
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sessions, was quantified to calculate the discriminatory index as
already explained.
Chemical Substances




All data were checked to verify whether normality and
homoscedasticity assumptions were met. Different treatments in
Experiment 1 were analyzed using Student’s t-test. Results
in Experiment 2 were analyzed by a two-way analysis
of variance (ANOVA), with hyposerotonergic condition,
and DPAT treatment as factors. Tukey’s test was used for
post hoc comparisons. Simple effects tests were performed
to analyze differences inside each condition. The OPS was
analyzed using the one-sample t-statistics in order to assess
whether the discrimination index, for each experimental
condition separately, differed significantly from 0. In all
cases, P < 0.05 was considered statistically significant.
A summary of tests employed and statistics is presented
in Table 1.
RESULTS
Experiment 1: Expression of the BDNF
Signaling Pathway
Protein-expression of BDNF isoforms and their receptors was
analyzed in the HC of 8-week PCPA- or vehicle-treated mice
(Figures 1A–H; see statistics in Table 1). Whereas no significant
differences were found between experimental groups for mBDNF,
its receptor TrkB, and proBDNF, expression of the proBDNF
receptor, p75, was significantly increased (p = 0.0427) in PCPA-
treated mice.
Experiment 2: Chronic Treatment With
the 5-HT1A Agonist, 8-OH-DPAT
Protein expression of the BDNF isoforms and their receptors
was analyzed in the HC of PCPA- and vehicle- chronically
treated mice receiving the 5-HT1A agonist DPAT or NaCl
0.9% (Figures 2A–E). Statistical analysis showed a significant
interaction between hyposerotonergic condition and DPAT
treatment for TrkB, proBDNF, and p75 receptor (for statistics, see
Table 1). Five weeks of PCPA administration induced a decreased
expression of proBDNF (p = 0.0085), and a tendency to increased
expression of p75 receptor (p = 0.0931), without significantly
modifying the expression of mBDNF or TrkB receptor. One
week administration of DPAT in vehicle-treated mice induced
a significant decrease in the expression of mBDNF (p = 0.0403)
and TrkB receptor (p = 0.0004), without significantly affecting
the levels of proBDNF or p75 receptor. Finally, administration
of DPAT to PCPA-treated mice induced a significant increase
in the expression of proBDNF (p = 0.0035) and p75 receptor
(p = 0.0239), without significantly modifying the levels of
mBDNF and TrkB receptor.
Experiment 3: Object Pattern Separation
(OPS) Test
In the set up, each mouse was assigned to a different position for
the moved object, identified as P1, P2, P3, P4, or P5 (Figure 3A).
As the objects were more separated from the original position, the
discrimination index became higher and increasingly different
from 0 (Figure 3B). Although results at P4 were unexpected, P5
resulted in an index significantly different from 0 (p = 0.0088),
whereas P3 showed a tendency for significance (p = 0.1203).
Altogether, as naïve mice are barely able to discriminate positions
in P3, the performance in this position can be improved, which
would result in a higher index and possibly, a p value <0.05. If
mice were tested in P5, where the discrimination index is high, a
difference between treated and control mice would not be seen,
as all of them are expected to perform well.
To study the role of newborn cells in the HC of mice
treated with PCPA or vehicle, animals were assayed in the
OPS at P3, given that subtle differences, i.e., a mild better
performance, between experimental groups were expected. Mice
were habituated to the open field for 3 consecutive days, for
10 min each day. All mice got habituated to the arena (Figure 3C),
with less distance traveled on each passing day (p < 0.05). No
significant difference in locomotor activity was seen between
mice treated with PCPA and vehicle. After a resting day, mice
were presented with two identical bottles for 4 min at P1. One
hour later, one of the bottles was moved to P3 and the animals
were left another 4 min to explore. Five mice were eliminated
from the data because they did not meet the criteria for minimal
exploration time of 10 s. A discrimination index was calculated, as
previously explained (Figure 3D). Whereas the index in control
mice was significantly different from 0 (p = 0.0435), PCPA-treated
mice showed a high p value (p = 0.6736).
DISCUSSION
Previous reports on hyposerotonergic mice demonstrated
increased survival of the newborn neurons generated in the adult
HC, with unchanged cell proliferation. The results presented
herein support the hypothesis about an interplay between the
BDNF signaling pathway in the HC and the serotonergic system
that could participate in the regulation of the survival of newborn
neurons. On the other hand, in our experimental conditions, a
facilitating role for supernumerary immature neurons on pattern
separation assays could not be confirmed.
Interestingly, a recent study, found increased mBDNF
expression in the prefrontal cortex of 1 month-old Tph2-deficient
rats (Brivio et al., 2018). Although this result observed in
serotonin-deficient rats was not reproduced in our mice model,
it is not completely unexpected. Indeed, several studies have
analyzed the effects of serotonin depletion on the neurogenic
process in rats and mice, revealing a clear dichotomy: whereas
lack of serotonin induces decreased survival of newborn
neurons in the DG of rats (Brezun and Daszuta, 1999, 2000;
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TABLE 1 | P values.
Paradigm or
assay
Parameter measured Statistical test Comparison Statistics Degree of freedom P value Figure
Western blot mBDNF signal relative
to tubulin
Student’s t test Treatment T = 1.056 21 0,3032 1A
Western blot TrkB signal relative to
tubulin
Student’s t test Treatment T = 0.9418 21 0,3570 1B
Western blot proBDNF signal relative
to tubulin
Student’s t test Treatment T = 1.577 18 0,1304 1C
Western blot P75 signal relative to
tubulin
Student’s t test Treatment T = 2.157 21 0,0427 1D
Western blot mBDNF signal relative
to tubulin
Two-way ANOVA Interaction F = 3,38 1 0,0817 2A
Factor food F = 13,19 1 0,0018
Factor injection F = 1,3E−03 1 0,9714
Tukey post-test Control – DPAT A
Control – NaCl AB
PCPA – NaCl AB
PCPA – DPAT B
Simple effects Inside food Ctrl F = 5,73 1 0,0403
PCPA F = 1,11 1 0,3161
Inside Inject NaCl F = 1,17 1 0,3039
DPAT F = 27,71 1 0,0005
Western blot TrkB signal relative to
tubulin
Two-way ANOVA Interaction F = 5,34 1 0,0322 2B
Factor Food F = 1,45 1 0,2433
Factor Injection F = 19,36 1 0,0003
Tukey post-test Control – DPAT A
Control – NaCl A
PCPA – NaCl AB
PCPA – DPAT B
Simple effects Inside food Ctrl F = 29,03 1 0,0004
PCPA F = 1,86 1 0,2027
Inside inject NaCl F = 4,23 1 0,0668
DPAT F = 1,44 1 0,2614
Western blot proBDNF signal relative
to tubulin
Two-way ANOVA Interaction F = 4,63 1 0,0453 2C
Factor food F = 0,43 1 0,5214
Factor injection F = 11,59 1 0,0032
Tukey post-test Control – DPAT A
Control – NaCl AB
PCPA – NaCl B
PCPA – DPAT B
Simple effects Inside food Ctrl F = 0,79 1 0,3973
PCPA F = 15,36 1 0,0035
Inside inject NaCl F = 11,25 1 0,0085
DPAT F = 0,68 1 0,4314
Western blot P75 signal relative to
tubulin
Two-way ANOVA Interaction F = 5,63 1 0,0284 2D
Factor food F = 22,70 1 0,0001
Factor Injection F = 6,79 1 0,0174
Tukey post-test Control – DPAT A
Control – NaCl A
PCPA – NaCl A
PCPA – DPAT B
(Continued)
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TABLE 1 | Continued
Paradigm or
assay
Parameter measured Statistical test Comparison Statistics Degree of freedom P value Figure
Simple effects Inside food Ctrl F = 0,39 1 0,5469
PCPA F = 7,07 1 0,0239
Inside inject NaCl F = 3,45 1 0,0931
DPAT F = 21,28 1 0,0013
Object pattern
separation
Discrimination index One sample t test P1 vs. 0 T = −0,03 – 0,9810 3B
P2 vs. 0 T = 0,30 – 0,7706
P3 vs. 0 T = 1,77 – 0,1203
P4 vs. 0 T = 1,03 – 0,3618
P5 vs. 0 T = 3,82 – 0,0088
Object pattern
separation
discrimination index One-way ANOVA Between positions F = 1,81 4 0,1544 3B
Object pattern
separation
Habituation Two-way ANOVA Interaction F = 0,14 2 0,8694 3C
Factor treatment F = 1,05 1 0,3131
Factor Day F = 17,98 2 <0,0001
Tukey post-test Day 1 vs. Day 2 <0,05
Day 1 vs. Day 3 <0,05
Day 2 vs. Day 3 ns
Object pattern
separation
Discrimination index One sample t test Control vs. 0 T = 2,18 – 0,0435 3D
PCPA vs. 0 T = 0,43 – 0,6736
FIGURE 1 | Protein expression of molecules from the BDNF signaling pathway determined by Western Blot and representative membranes. (A) mBDNF. (B) TrkB.
(C) proBDNF. (D) p75 in hyposerotonergic (PCPA-treated) or control (vehicle-treated) mice for 4 weeks. (E–H) Representative membrane showing signal for TrkB,
p75, pro-BDNF, and mBDNF in Control and PCPA-treatd mice. Data are expressed as mean ± S.E.M., n = 11 (control) and 12 (PCPA). ∗p < 0.05.
Banasr et al., 2001; Jha et al., 2006; Kohl et al., 2016), the
opposite effect has been demonstrated in serotonin-depleted
mice (Diaz et al., 2013; Karabeg et al., 2013; Jia et al., 2014;
Song et al., 2016, 2017). Therefore, caution is required when
comparing neurogenic effects in these two rodent species. Indeed,
there are few reports conducted in hyposerotonergic mice. In
the present study, a mice model in which serotonin depletion
was pharmacologically induced, after inhibition of the Tph rate-
limiting enzyme, was employed. This pharmacological model,
allows us to specifically target the process of adult neurogenesis,
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FIGURE 2 | Effect of 8-OH-DPAT on the protein expression of molecules from the BDNF signaling pathway in the HC, determined by Western Blot. (A) mBDNF.
(B)TrkB. (C) proBDNF. (D) p75 in hyposerotonergic (PCPA-treated) or control (vehicle-treated) mice receiving the 5-HT1A agonist 8-OH-DPAT (striped bars) or NaCl
(white bars). (E) Representative membrane showing signal for p75 (75 kDa) and tubuline (52 kDa). 1: Control-NaCl. 2: Control-DPAT. 3: PCPA-NaCl. 4: PCPA-DPAT.
Data are expressed as mean ± S.E.M., n = 6 per experimental group.∗p < 0.05.
FIGURE 3 | Object pattern separation (OPS) test. (A) Scheme of the arena and objects used for the test. The x represents the different possible positions for the
moved object. Full circles represent the bottles used as objects. (B) Discrimination index for the different new positions for the moved object in naive mice.
(C) Locomotor activity in an open field along 3 days. (D) Discrimination index in the OPS of mice chronically treated with PCPA or vehicle (control) for 8 weeks. Data
are expressed as mean ± SEM., n = 13 (Control) and 15 (PCPA).∗p < 0.05; ∗∗p < 0.01.
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in opposition to transgenic mice like Pet1−/− (Diaz et al., 2013),
Tph2−/−, SERT−/− (Kronenberg et al., 2016) mice in which
constitutive depletion of serotonin affects as well the process of
developmental neurogenesis that occurs during the first 2 weeks
of life. In our experimental conditions, an increased protein
expression of the p75 receptor was detected in the HC of mice
after 4 and 5 weeks of PCPA administration. In addition, after
5 weeks of PCPA treatment, reduced protein expression of the
p75 receptor ligand pro-BDNF was also evident. Since pro-BDNF
is known to facilitate cell death (Barker, 2004), the decreased
levels revealed herein in the HC of hyposerotonergic mice are in
line with the increased cell survival previously reported in mice
treated with PCPA for 8 weeks (Diaz et al., 2013). On the contrary,
we did not observe any change in the expression of mBDNF and
its receptor TrkB after chronic PCPA. These observations are
in agreement with a recent article conducted in mice in which
serotonin synthesis disruption was induced during adulthood
(Pratelli et al., 2017). Indeed, Tph2 was specifically knocked-out
at post-natal day 60 and hippocampal BDNF and TrkB receptor
expression was unchanged compared to wild type mice. On the
contrary, studies on the HC of mice with constitutive serotonin
depletion showed an increase of BDNF mRNA (Migliarini et al.,
2013) as well as of BDNF protein levels (Kronenberg et al., 2016).
All in all, these results suggest that lack of serotonin induces
dichotomic responses in the BDNF signaling pathway depending
on the time of onset of serotonin depletion.
Stimulation of 5-HT1A receptors during 4 weeks was described
to increase cell proliferation (Santarelli et al., 2003). However,
shorter periods of stimulation, i.e., 1–2 week, did not induced
neurogenic effects (Banasr et al., 2004; Huang and Herbert, 2005;
Klempin et al., 2010; Diaz et al., 2013). Here, in our study, 1-
week administration of the 5-HT1A agonist promoted a decreased
protein expression of mBDNF and TrkB receptor in the HC
of control mice. To our knowledge, the only data published in
mice so far, concerned animals receiving DPAT from postnatal
day 1 to 21, yielding a trend to decreased expression of BDNF
mRNA in the HC (Ishikawa and Shiga, 2017). Interestingly, in the
case of hyposerotonergic mice, 1-week stimulation of the 5-HT1A
receptor did not significantly affect the mBDNF/TrkB pathway,
but induced an increased protein expression of proBDNF and
p75 receptor. Considering the pro-apoptotic properties reported
for this complex (Barker, 2004), its enhanced expression could
be playing a role in the reestablishment of cell survival in DPAT-
treated hyposerotonergic mice (Diaz et al., 2013). All in all, our
results suggest that the BDNF signaling pathway is differentially
affected according to the serotonergic neurotransmission context.
The object pattern separation task allows the detection of
subtle differences in mice performance (van Hagen et al.,
2015). Surprisingly, PCPA-treated mice failed to get an index
significantly different from 0, as it was the case for control mice.
Although PCPA-treated mice have higher number of immature
neurons in the HC (Diaz et al., 2013), this result was not
completely unexpected, and given that we have previously found
no improvement in the performance of hyposerotonergic mice in
the contextual fear discrimination learning test (Diaz et al., 2013).
As serotonin is involved in several different processes in the brain,
reduced serotonin levels may impair cognitive abilities required
to solve this kind of tests, independently of the number of
immature neurons. It is interesting to mention that when setting
up the OPS test, we were able to reproduce the discrimination
curve reported in the original work (van Hagen et al., 2015),
except for the position 4, where we could not get a discrimination
index intermediate between P3 and P5. However, this unforeseen
fact do not appear to interfere with the obtained results.
The observations made in our experimental conditions shed
light on the role of the BDNF isoforms in the regulation of the
neurogenic process that takes place in the HC of adult mice,
under different configurations of the serotonergic system. This
knowledge is key to propose new therapeutic targets for the
development of more efficacious drugs.
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